// App-Quantinova.ai

295 : The cytosine deaminase APOBEC3B affects responses to therapy in estrogen receptor positive breast cancer cells

Researchers

Presenter

  • Kelly S. LaPara

Principal Investigators

  • Emily Law

  • Reuben Harris

  • Douglas Yee

Medical Centers

  • Masonic Cancer Center, University of Minnesota, Minneapolis, MN

  • Biochemistry, Molecular Biology and Biophysics Department, Masonic Cancer Center, Howard Hughes Medical Institute, University of Minnesota, Minneapolis, MN

  • Biochemistry, Molecular Biology and Biophysics Department, Masonic Cancer Center, Howard Hughes Medical Institute, University of Minnesota, Minneapolis, MN

  • Masonic Cancer Center, University of Minnesota, Minneapolis, MN

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Breast cancer

  • Solid malignancies

Biomarkers

  • Apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3B

Drug/Treatment

  • Adrucil injection

  • Tamoxifen

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved